$7.00
-0.33-4.5%
Last update: Oct 30, 7:32 PM
Olema Pharmaceuticals inc
OLMANASDAQ
Olema Pharmaceuticals (OLMA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.54 | $-0.52 | $-0.44 |
| Actual | $-0.61 | $-0.52 | $-0.50 | $-0.49 |
| Surprise | -8.93% | +3.70% | +3.85% | -11.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.63 | $-0.65 | $-0.62 | $-0.66 |
| Revenue | ||||
| Consensus | $2.0M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.61 | $-0.56 | -8.93 % |
| Q1 | May 12, 2026 | $-0.52 | $-0.54 | 3.70 % |
| Q4 | Mar 16, 2026 | $-0.50 | $-0.52 | 3.85 % |
| Q3 | Nov 10, 2025 | $-0.49 | $-0.44 | -11.4 % |
